在早期药物发现过程中做出正确的决策
Virginie Sandrin1, Bigna Wörsdörfer1, Sam Vardy2
1Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, 4070 Basel, Switzerland.
Drug discovery today
|May 8, 2024
概括
本研究介绍了早期药物发现计划的决策质量过程. 它提供了一个可视化的路线图,以优化项目计划,改善复杂的研究环境中的决策.
科学领域:
- 药物发现 药物发现 药物发现
- 决策科学 决策科学 决策科学
- 项目管理 项目管理
背景情况:
- 早期药物发现涉及复杂的,多学科的挑战,有许多未知因素.
- 有效的决策对于早期药物发现的成功至关重要.
- 对于这些早期阶段的合理规划方法是不发达的.
研究的目的:
- 为早期药物发现提供量身定制的定性"决策质量"流程.
- 为特定的研究情况提供优化项目计划的指导.
- 引入视觉流程图格式,用于创建决策路线图.
主要方法:
- 开发一个量身定制的,定性决策质量流程.
- 为项目计划创建视觉流程图格式.
- 使用现实生活中的药物发现实例来说明过程.
主要成果:
- 一个结构化的过程,以提高早期药物发现的决策质量.
- 视觉决策路线图,指导关键活动和决策.
- 实施拟议的规划流程的实际建议.
结论:
- 建议的决策质量流程和路线图可以优化早期药物发现项目规划.
- 这种方法解决了复杂研究工作的战略规划中的一个关键差距.
- 提供了实施指南,以便在现实场景中切实应用.
相关概念视频
Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Structure-Activity Relationships and Drug Design
701
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
701
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Drug Administration and Therapy Phases: Overview
451
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
451
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K


